ScreenerHero

BBM Blueberries Medical Corp.

CNQ · CA · Healthcare · Drug Manufacturers - Specialty & Generic · blueberriesmed.com
0.0070USD0.0100 CAD · CNQ0.00%Mkt Cap: 4.07M USDP/E: —

Blueberries Medical Corp., a consumer science company, engages in the commercialization of medicinal cannabis and related products in Colombia. The company produces and distributes psychoactive and non-psychoactive canna…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all Drug Manufacturers - Specialty & Generic
MRK
Merck KGaA
$71.89BUSDP/E 28.1
TAK
Takeda Pharmaceutical Company Limited
$68.47BUSDP/E 306.1
GALD
Galderma Group AG
$53.24BUSDP/E 66.0
TEVA
Teva Pharmaceutical Industries Limited
$51.92BUSDP/E 103.5
SDZ
Sandoz Group AG
$43.66BUSDP/E 72.3
HLN
Haleon plc
$40.25BUSDP/E 18.7
ZTS
Zoetis Inc.
$34.06BUSDP/E 14.3
HLN
Haleon plc
$40.03BUSDP/E 19.2
UTHR
United Therapeutics Corporation
$25.18BUSDP/E 22.3
VTRS
Viatris Inc.
$23.87BUSD
NBIX
Neurocrine Biosciences, Inc.
$16.94BUSDP/E 24.8
SOBI
Swedish Orphan Biovitrum AB (publ)
$16.42BUSDP/E 25.0
IPN
Ipsen S.A.
$15.16BUSDP/E 27.0
ELAN
Elanco Animal Health Incorporated
$13.39BUSD
RDY
Dr. Reddy's Laboratories Limited
$12.29BUSDP/E 40.9
HLUN-B
H. Lundbeck A/S
$8.71BUSDP/E 14.5
HLUN-A
H. Lundbeck A/S
$8.54BUSDP/E 14.2
KRK
Krka, d. d.
$8.50BUSDP/E 19.2
ALKS
Alkermes plc
$7.90BUSD
KNSA
Kiniksa Pharmaceuticals International, plc
$7.57BUSDP/E 73.0

Key Statistics

Company
Market Cap4.07M USD
Enterprise Value3.75M USD
Revenue (TTM)195.12K USD
Gross Profit103.68K USD
Net Income (TTM)-1.17M USD
Revenue/Share0.0007 USD
Last Price0.0070 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA09609Y1016
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-7.57
EV/Revenue19.19
P/S20.84
P/B—
EPS (TTM)0.00 USD
EPS (Forward)—
52W Range
0.00700% of range0.0140
52W High0.0140 USD
52W Low0.0070 USD
Profitability
Gross Margin47.34%
Oper. Margin-271.97%
EBITDA Margin-253.69%
Profit Margin-533.44%
ROE-518.68%
ROA-245.12%
ROIC-251.79%
ROCE-429.35%
Growth
Revenue Growth-37.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-871.86K USD
CapEx (TTM)—
FCF Margin7.86%
FCF Yield0.38%
Net Debt272.95K USD
Net Debt/EBITDA-0.55
Net Debt/FCF17.79
Balance Sheet
Debt/Equity0.43
Current Ratio0.44
Quick Ratio0.32
Book Value/Sh0.00 USD
Cash/Share0.00 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJul 4, 2018
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.579.71M
Float128.01M
Insiders74.00%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short54
Short (prev mo.)54
Technical
SMA 500.0097 (-28.1%)
SMA 2000.0097 (-27.4%)
Beta2.55
S&P 52W Chg13.09%
Avg Vol (30d)45.87K
Avg Vol (10d)64.80K
Technical Indicators
RSI (14)34.1
MACD-0.0012
MACD Signal-0.0007
MACD Hist.-0.0005
BB Upper0.0127 USD
BB Middle0.0093 USD
BB Lower0.0059 USD
BB Width73.87%
ATR (14)0.0005 USD
Vol Ratio (20d)0.24x

About Blueberries Medical (CNSX: BBM)

›

Blueberries Medical (CNSX: BBM) is listed on the Canadian Securities Exchange, where its shares trade in CAD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector.

The shares were at 0.0100 CAD on 12 November 2026, down 33.3% over 52 weeks. Its 52-week range is 0.0100 CAD to 0.0200 CAD, and it trades at the bottom of that range.

Its market capitalisation is 5.80M CAD.

Blueberries Medical reports an operating margin of -272.0% and revenue down 37.3% year over year.

Its debt exceeds its cash by 389.17K CAD, a debt-to-equity ratio of 0.43. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.

Compare BBM with MRK and TAK →More Canada stocks: Canadian Stock Screener →